StockData.org
  • Home
  • Documentation
  • Pricing
  • Contact Us
  • Login
  • Sign Up

ADMS

Adamas Pharmaceuticals Inc

Sign up for free!

Get instant access to stock market data and news with our free APIs.

Sign up now

Latest news data for ADMS

Supernus Pharmaceuticals: Shares Could Get Cheaper (NASDAQ:SUPN)
seekingalpha.com
Global Alzheimers Disease Diagnostics and Therapeutics Market Size to grow USD 21704.4 Million by 2030 | CAGR of 5.5%
globenewswire.com
Parkinson’s Disease Market Size Will Achieve USD 6,705 Million by 2030 growing at 11.5% CAGR - Exclusive Report by Acumen Research and Consulting
globenewswire.com
Global Alzheimer's Therapeutics Market Report 2022-2030 - Incidence and Cost Burden of Dementia Associated with AD is Expected to Boost Market Growth
prnewswire.com
8 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
insidermonkey.com
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
prnewswire.com
With 6.3% CAGR, Multiple Sclerosis Drugs Market Size Worth USD 41.99 Billion in 2028
globenewswire.com
Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
globenewswire.com
Acer Therapeutics : Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update - Form 8-K
marketscreener.com
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
globenewswire.com

News sentiment (24 hrs)

+0.00

Intraday data

Historical data

maximum of 5 years displayed, 40+ years of data available via API

StockData.org © Copyright 2023

  • FAQs
  • Terms and Conditions
  • Privacy